These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18079527)

  • 1. Drug companies expected to get more leeway in communicating with patients in Europe.
    Sayburn A
    BMJ; 2007 Dec; 335(7632):1228. PubMed ID: 18079527
    [No Abstract]   [Full Text] [Related]  

  • 2. The European pharmaceutical industry: coming to a screen near you?
    Rutter P; Gilbody S
    J R Soc Med; 2008 Oct; 101(10):485-8. PubMed ID: 18840863
    [No Abstract]   [Full Text] [Related]  

  • 3. Belgium to tighten drug advertising laws.
    Watson R
    BMJ; 2006 May; 332(7550):1110. PubMed ID: 16690651
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct-to-consumer advertising under fire.
    Bull World Health Organ; 2009 Aug; 87(8):576-7. PubMed ID: 19705005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Merck to pay $58m in settlement over rofecoxib advertising.
    Charatan F
    BMJ; 2008 May; 336(7655):1208-9. PubMed ID: 18511780
    [No Abstract]   [Full Text] [Related]  

  • 6. Charter challenge of ban on direct-to-consumer advertising to be heard by Ontario court in mid-June.
    Silversides A
    CMAJ; 2009 Jul; 181(1-2):E5-6. PubMed ID: 19581607
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA warning to manufacturers of AIDS drugs.
    Josefson D
    BMJ; 2001 May; 322(7295):1143. PubMed ID: 11348904
    [No Abstract]   [Full Text] [Related]  

  • 8. [The regulation of medical visits: necessary but insufficient].
    Madridejos Mora R
    Aten Primaria; 2003 Dec; 32(10):562-3. PubMed ID: 14697178
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct to consumer advertisement: The world of the market place.
    Howell JV
    BMJ; 2007 Oct; 335(7622):683-4. PubMed ID: 17916818
    [No Abstract]   [Full Text] [Related]  

  • 10. Should drug companies be allowed to talk directly to patients? NO.
    Garlick W
    BMJ; 2003 Jun; 326(7402):1302-3. PubMed ID: 12805164
    [No Abstract]   [Full Text] [Related]  

  • 11. Prohibition against off-label drug promotion challenged.
    Woodward C
    CMAJ; 2012 Mar; 184(5):518. PubMed ID: 22353585
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct to consumer advertising: A cynical consultation exercise?
    Medawar C
    BMJ; 2008 Apr; 336(7648):787. PubMed ID: 18403502
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct to consumer advertising: Include cost of treatment.
    Glaser AN
    BMJ; 2008 Apr; 336(7648):788. PubMed ID: 18403508
    [No Abstract]   [Full Text] [Related]  

  • 14. The Future of Drug-Pricing Transparency.
    Feldman WB; Rome BN; Avorn J; Kesselheim AS
    N Engl J Med; 2021 Feb; 384(6):489-491. PubMed ID: 33440087
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of direct-to-consumer advertising.
    Navarro RP
    Manag Care Interface; 1998 Nov; 11(11):79-80, 82. PubMed ID: 10187419
    [No Abstract]   [Full Text] [Related]  

  • 16. Is banning direct-to-consumer advertising consistent with bioethical principles?
    O'Hara KM
    JAAPA; 2010 Aug; 23(8):54, 56-7. PubMed ID: 20821915
    [No Abstract]   [Full Text] [Related]  

  • 17. A decade of direct-to-consumer advertising of prescription drugs.
    Donohue JM; Cevasco M; Rosenthal MB
    N Engl J Med; 2007 Aug; 357(7):673-81. PubMed ID: 17699817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a nocebo response that results from disease awareness campaigns and advertising in Australia, and can this effect be mitigated?
    Benson S; Hunter D
    J Med Ethics; 2018 Sep; 44(9):621-625. PubMed ID: 29764983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving Communication with Healthcare Professionals in the Pharmaceutical Space: Current Trends and Future Perspectives.
    Krendyukov A; Nasy D
    Pharmaceut Med; 2020 Aug; 34(4):247-256. PubMed ID: 32557342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.